featured
Transitioning From Insulin Therapy to DPP-4 Inhibitors in Patients With Type 2 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Geriatric nursing (New York, N.Y.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Transitioning from insulin to dipeptidyl-peptidase 4 (DPP-4) inhibitors for type 2 diabetes
Geriatr Nurs 2022 Jul 01;46(2022)86-89, I Hamrick, MJ Goblirsch, WJ Tuan, F BeckhamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.